Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBCWW) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $17.9 million.

  • SBC Medical Group Holdings' Gains from Investment Securities rose 1834.32% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.5 million, marking a year-over-year decrease of 28.4%. This contributed to the annual value of $30.2 million for FY2024, which is 6947.83% up from last year.
  • SBC Medical Group Holdings' Gains from Investment Securities amounted to $17.9 million in Q3 2025, which was up 1834.32% from -$939836.0 recorded in Q2 2025.
  • SBC Medical Group Holdings' Gains from Investment Securities' 5-year high stood at $20.6 million during Q1 2025, with a 5-year trough of -$1.1 million in Q4 2024.
  • Over the past 3 years, SBC Medical Group Holdings' median Gains from Investment Securities value was $10.2 million (recorded in 2023), while the average stood at $9.1 million.
  • Examining YoY changes over the last 5 years, SBC Medical Group Holdings' Gains from Investment Securities showed a top increase of 2723.61% in 2025 and a maximum decrease of 513879.48% in 2025.
  • SBC Medical Group Holdings' Gains from Investment Securities (Quarter) stood at $5.2 million in 2023, then plummeted by 120.88% to -$1.1 million in 2024, then skyrocketed by 1739.19% to $17.9 million in 2025.
  • Its last three reported values are $17.9 million in Q3 2025, -$939836.0 for Q2 2025, and $20.6 million during Q1 2025.